Literature DB >> 18511053

Bioluminescent imaging of Trypanosoma cruzi infection.

Kenneth V Hyland1, Sofya H Asfaw, Cheryl L Olson, Melvin D Daniels, David M Engman.   

Abstract

Chagas disease, caused by infection with the protozoan parasite Trypanosoma cruzi, is a major public health problem in Central and South America. The pathogenesis of Chagas disease is complex and the natural course of infection is not completely understood. The recent development of bioluminescence imaging technology has facilitated studies of a number of infectious and non-infectious diseases. We developed luminescent T. cruzi to facilitate similar studies of Chagas disease pathogenesis. Luminescent T. cruzi trypomastigotes and amastigotes were imaged in infections of rat myoblast cultures, which demonstrated a clear correlation of photon emission signal strength to the number of parasites used. This was also observed in mice infected with different numbers of luminescent parasites, where a stringent correlation of photon emission to parasite number was observed early at the site of inoculation, followed by dissemination of parasites to different sites over the course of a 25-day infection. Whole animal imaging from ventral, dorsal and lateral perspectives provided clear evidence of parasite dissemination. The tissue distribution of T. cruzi was further determined by imaging heart, spleen, skeletal muscle, lungs, kidneys, liver and intestines ex vivo. These results illustrate the natural dissemination of T. cruzi during infection and unveil a new tool for studying a number of aspects of Chagas disease, including rapid in vitro screening of potential therapeutical agents, roles of parasite and host factors in the outcome of infection, and analysis of differential tissue tropism in various parasite-host strain combinations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18511053      PMCID: PMC2583089          DOI: 10.1016/j.ijpara.2008.04.002

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  53 in total

Review 1.  Parasitic diseases of the heart.

Authors:  Louis V Kirchhoff; Louis M Weiss; Murray Wittner; Herbert B Tanowitz
Journal:  Front Biosci       Date:  2004-01-01

2.  Tissue tropism of different Trypanosoma cruzi strains.

Authors:  R C Melo; Z Brener
Journal:  J Parasitol       Date:  1978-06       Impact factor: 1.276

3.  Trypanosoma cruzi: quantification in tissues of experimentally infected mice by limiting dilution analysis.

Authors:  M P Nunes; S G Coutinho; J A Louis; W J Souza
Journal:  Exp Parasitol       Date:  1990-02       Impact factor: 2.011

4.  On evasion of Trypanosoma cruzi from the host immune response. Lymphoproliferative responses to trypanosomal antigens during acute and chronic experimental Chagas' disease.

Authors:  F Kierszenbaum
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

5.  Amplification of Trypanosoma cruzi-specific DNA sequences in formalin-fixed raccoon tissues using polymerase chain reaction.

Authors:  Michael J James; Michael J Yabsley; Oscar J Pung; Mario J Grijalva
Journal:  J Parasitol       Date:  2002-10       Impact factor: 1.276

6.  MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer.

Authors:  Catherine M Shachaf; Andrew M Kopelman; Constadina Arvanitis; Asa Karlsson; Shelly Beer; Stefanie Mandl; Michael H Bachmann; Alexander D Borowsky; Boris Ruebner; Robert D Cardiff; Qiwei Yang; J Michael Bishop; Christopher H Contag; Dean W Felsher
Journal:  Nature       Date:  2004-10-10       Impact factor: 49.962

7.  Persistence of Trypanosoma cruzi antigens in the inflammatory lesions of chronically infected mice.

Authors:  A Ben Younès-Chennoufi; M Hontebeyrie-Joskowicz; V Tricottet; H Eisen; M Reynes; G Said
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

8.  Trypanosoma cruzi: explant organ cultures from mice with chronic Chagas' disease.

Authors:  R E McCabe; S Meagher; B Mullins
Journal:  Exp Parasitol       Date:  1989-05       Impact factor: 2.011

9.  Immunofluorescence as an adjunct to the histopathologic diagnosis of Chagas' disease.

Authors:  F W Chandler; J C Watts
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

10.  Cryptic epitope explains the failure of a monoclonal antibody to bind to certain isolates of Trypanosoma cruzi.

Authors:  L V Kirchhoff; S Hieny; G M Shiver; D Snary; A Sher
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

View more
  28 in total

Review 1.  Noninvasive biophotonic imaging for studies of infectious disease.

Authors:  Nuria Andreu; Andrea Zelmer; Siouxsie Wiles
Journal:  FEMS Microbiol Rev       Date:  2010-10-19       Impact factor: 16.408

2.  Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs.

Authors:  Julio A Urbina; James H McKerrow
Journal:  Antimicrob Agents Chemother       Date:  2015-12       Impact factor: 5.191

3.  Transgenic parasites accelerate drug discovery.

Authors:  Ana Rodriguez; Rick L Tarleton
Journal:  Trends Parasitol       Date:  2012-01-23

4.  Methodological advances in drug discovery for Chagas disease.

Authors:  Juan M Bustamante; Rick L Tarleton
Journal:  Expert Opin Drug Discov       Date:  2011-06       Impact factor: 6.098

5.  High-content imaging for automated determination of host-cell infection rate by the intracellular parasite Trypanosoma cruzi.

Authors:  L L Nohara; C Lema; J O Bader; R J Aguilera; I C Almeida
Journal:  Parasitol Int       Date:  2010-08-03       Impact factor: 2.230

6.  Evidence for subpopulations of Listeria monocytogenes with enhanced invasion of cardiac cells.

Authors:  Francis Alonzo; Linda D Bobo; Daniel J Skiest; Nancy E Freitag
Journal:  J Med Microbiol       Date:  2011-01-25       Impact factor: 2.472

Review 7.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

8.  In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds.

Authors:  Adriana M C Canavaci; Juan M Bustamante; Angel M Padilla; Cecilia M Perez Brandan; Laura J Simpson; Dan Xu; Courtney L Boehlke; Rick L Tarleton
Journal:  PLoS Negl Trop Dis       Date:  2010-07-13

Review 9.  Putting Infection Dynamics at the Heart of Chagas Disease.

Authors:  Michael D Lewis; John M Kelly
Journal:  Trends Parasitol       Date:  2016-09-06

10.  Non-invasive in vivo study of the Trypanosoma vivax infectious process consolidates the brain commitment in late infections.

Authors:  Simon D'Archivio; Alain Cosson; Mathieu Medina; Thierry Lang; Paola Minoprio; Sophie Goyard
Journal:  PLoS Negl Trop Dis       Date:  2013-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.